Kewaunee Scientific Corporation reported its financial results for the third quarter and nine months ended January 31, 2026, showing a notable increase in revenue and profitability compared to the previous fiscal period. The company achieved net sales of $69.4 million for the quarter, up from $67.2 million in the same period last year, and $210.6 million for the nine months, a significant rise from $163.3 million. The gross profit for the quarter was $18.5 million, yielding a gross profit margin of 26.7%, slightly down from 27.4% in the prior year. For the nine-month period, gross profit increased to $59.2 million, with a margin of 28.1%, compared to 27.4% in the previous year.
The increase in sales was primarily driven by the acquisition of Nu Aire, which Kewaunee completed on November 1, 2024, for $55 million. This acquisition has expanded Kewaunee's product offerings in laboratory equipment, contributing to a 29.6% increase in domestic sales for the nine-month period. International sales also saw a 27% increase, reaching $50.1 million, largely due to higher billings in the Indian market. However, domestic sales for the quarter experienced a slight decline of 2%, reflecting a challenging market environment.
Operationally, Kewaunee's order backlog stood at $183.2 million as of January 31, 2026, down from $221.6 million a year earlier. The company reported a decrease in cash and cash equivalents to $8.2 million from $14.9 million at the end of the previous fiscal year. The total assets decreased to $176 million, while total liabilities also fell to $103.4 million. The company’s employee headcount remained stable, with approximately 2,866,000 shares of common stock outstanding.
Looking ahead, Kewaunee anticipates continued volatility in project delivery and construction schedules, particularly during the winter months. The company remains focused on leveraging the Nu Aire acquisition to enhance its market position and diversify its product offerings. Kewaunee's management expressed confidence in its strategic investments and operational capabilities to support growth, despite the uncertainties in the broader economic landscape. The company is committed to maintaining its focus on innovation and customer service to navigate the challenges ahead.
About KEWAUNEE SCIENTIFIC CORP /DE/
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. Its offerings include steel and wood casework, fume hoods, safety cabinets, incubators, and freezers. Serving global markets in pharmaceuticals, biotech, education, and healthcare, the company leverages a diversified product portfolio, international subsidiaries, and strategic acquisitions to meet the needs of laboratory and research facilities worldwide.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.